[1]国际肝胆胰学会中国分会, 中华医学会外科学分会肝脏外科学组. 胆管癌诊断与治疗——外科专家共识[J]. 临床肝胆病杂志, 2015, 31: 12-16. [2]Losman JA, Kaelin WG. What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer[J]. Genes Dev, 2013, 27: 836-852. [3]Wang P, Dong Q, Zhang C, et al. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas[J]. Oncogene, 2013, 32: 3091-3100. [4]Farshidfar F, Zheng S, Gingras MC, et al. Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles[J]. Cell Rep, 2017, 18: 2780-2794. [5]Colaprico A, Silva TC, Olsen C, et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data[J]. Nucleic Acids Res, 2015, 44: e71. [6]Maksimovic J, Phipson B, Oshlack A. A cross-package Bioconductor workflow for analysing methylation array data [version 3; peer review: 4 approved][J]. F1000Research, 2017, 5: 1281. [7]Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies[J]. Nucleic Acids Res, 2015, 43: e47.doi:10.1093/nar/gkv007. [8]Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2[J]. Genome Biol, 2014, 15: 550. [9]Yu G, Wang L, Han Y, et al. Cluster Profiler: an R package for comparing biological themes among gene clusters[J]. OMICS, 2012, 16: 284-287. [10]Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks[J]. Genome Res, 2003, 13: 2498-2504. [11]Bader GD, Hogue CWV. An automated method for finding molecular complexes in large protein interaction networks[J]. BMC Bioinformatics, 2003, 4: 2. [12]Xu L, Liu H, Yu J, et al. Methylation-induced silencing of maspin contributes to the proliferation of human glioma cells[J]. Oncol Rep, 2016, 36: 57-64. [13]Steffan JJ, Koul HK. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor[J]. Cancer Lett, 2011, 310: 109-117. [14]Turcan S, Rohle D, Goenka A, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype[J]. Nature, 2012, 483: 479-483. |